Veterinary Vaccines Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023

The veterinary Vaccines market report gives a comprehensive outlook on veterinary vaccines market across the globe with special emphasis on key regions such as North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa (MEA). The report on veterinary vaccines market gives historical, current, and future market sizes (US$ Mn) on the basis of product type, disease type, vaccine type, distribution channel, and geographic regions. This report studies veterinary vaccines market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, the veterinary vaccines market report includes animal demographics; regulatory scenario, top meat producing countries, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed veterinary vaccines market to better equip clients with possible investment opportunities across the regions (Regional Investment Hot-Spots) and market unmet needs (Product Opportunities). Key stakeholders of the veterinary vaccines market report include suppliers, manufacturers, marketers, policymakers, and veterinary healthcare service providers engaged in manufacturing and supply of veterinary vaccines products.

A sample of this report is available upon request @
https://www.precisionbusinessinsights.com/market-reports/global-veterinary-vaccines-market/#ulp-4H8Z4LpNMLEuOnnx


Global Veterinary Vaccines Market:

The veterinary vaccines market estimated to be valued US$ 6,029 Mn in 2017 and poised to grow at CAGR of 5.6% over 2017-2023. The market for veterinary vaccines projected to reach US$ 8,368 Mn by 2023 owing to rising immunization programmes in animals and increasing stakeholder involvement to contain the disease in animals.

Rising meat and animal trade restrictions expected to drive the veterinary vaccine market over the forecast period

The rise in demand for safe and effective meat for consumption and rising trade restriction of meat and animal owing to zoonotic diseases expected to create demand for veterinary vaccines over the forecast period. For instance, Global Rinderpest Eradication Program aims at vaccination, trade restrictions, and surveillance of rinderpest in animals. Moreover, market growth is driven by improving food security and rising human and pet bondage adoption in recent times.

Constrained resources impeding the market revenue growth

The growth of veterinary vaccines Market expected to hinder over forecast period owing to lack of cold chain infrastructure for vaccine storage and transportation in several developing and underdeveloped economies. Moreover, the dearth of diseases surveillance data for carving out effective immunization programs expected to impede veterinary vaccine market growth over the forecast period.

Europe accounted for larger market revenue share in global veterinary vaccines market

Europe accounted for larger revenue share in global veterinary vaccines market with moderate CAGR. There has been increased in awareness among cattlemen in U.S. regarding animal rearing, animal health and proper vaccination and judicious use of antibiotics in animals, which are driving the market revenue growth in the region. Asia Pacific market projected to grow at significant rate owing large pool of animal population and increased consumption and trade of meat.

To view TOC of this report is available upon request @
https://www.precisionbusinessinsights.com/market-reports/global-veterinary-vaccines-market/#ulp-c654SbFYO64MsOhu


Competition Assessment

Key players profiled in the global veterinary vaccines market include:
• Bayer AG (Germany)
• Boehringer Ingelheim GmbH (Germany)
• Ceva Santé Animale (France)
• Eli Lilly and Company (U.S)
• Hester Biosciences (India)
• Merck & Co., Inc. (U.S)
• Vétoquinol S.A. (France)
• Virbac S.A. (France)
• Zoetis Inc. (U.S)

Need more information about this report @
https://www.precisionbusinessinsights.com/market-reports/global-veterinary-vaccines-market/#ulp-14mlyhjMGhVjZqa3

Players in the veterinary vaccine market are launching the products in newer markets to garner larger market share in the market. For instance in 2015, Boehringer Ingelheim animal health launched two new vaccines in Europe market which offer sustainable control of Porcine Reproductive and Respiratory Syndrome (PRRS) in pigs.

Key Findings of the Report:

• Veterinary Vaccines market expanding at 5.6% CAGR over 2017 to 2013 to reach market value of US$ 8,368 Mn by 2023 owing to increased adoption pet animals and rising meat consumption
• Based on product type livestock vaccines accounted for larger market revenue share in 2016 and projected gain market revenue share over the forecast period
• Live attenuated vaccines segment garnered larger revenue share in global 2016 and projected to remain dominant over the forecast period
• Players focusing on launching products to retain market position in global veterinary vaccines market
Key Features of the Report:

• The report provides granular level information about the market size, regional market share, historic market (2012-2016) and forecast (2017-2023)
• The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
• The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
• The report tracks recent innovations, key developments and startup’s details that are actively working in the market
• The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
• The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market
Detailed Segmentation

By Product Type
• Live Stock Vaccines
o Bovine Vaccines
o Poultry Vaccines
o Small Ruminants Vaccines
• Companion Animal Vaccine
o Canine Vaccines
o Feline Vaccines
• Porcine Vaccines
• Equine Vaccines
• Others

By Disease Type
• Live Stock Diseases
o Foot and Mouth Diseases
o Brucellosis
o Infectious Bronchitis
o Marek’s Disease
o Newcastle Disease
o Others
• Companion Animal Diseases
o Canine Distemper
o Canine Parvovirus
o Feline Rabies
o Others
• Equine Diseases
• Porcine Diseases
• Aquaculture Diseases

By Vaccine Type
• Live Attenuated Vaccines
• Inactivated Vaccines
• Recombinant vaccines
• Toxoid vaccines
• Conjugate Vaccines
• DNA Vaccines
• Subunit Vaccines

Distribution Channel
• Veterinary Pharmacies
• Veterinary Hospitals
• Veterinary Clinics
• E-Commerce

Get full summery@
https://www.precisionbusinessinsights.com/market-reports/global-veterinary-vaccines-market


Geography
• North America
o US
o Canada
• Europe
o Germany
o France
o UK
o Italy
o Spain
o Russia
o Poland
o Rest of Europe
• Asia-Pacific
o Japan
o China
o India
o Australia & New Zealand
o ASEAN (Includes Indonesia, Thailand, Vietnam, Philippines, Malaysia, and Others)
o South Korea
o Rest of Asia-Pacific
• Latin America
o Brazil
o Mexico
o Argentina
o Venezuela
o Rest of Latin America
• The Middle East and Africa (MEA)
o Gulf Cooperation Council (GCC) Countries
o Israel
o South Africa
o Rest of MEA

About Precision Business Insights

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

Contact to Precision Business Insights,

Kemp House,
152 – 160 City Road,
London EC1V 2NX

Email: sales@precisionbusinessinsights.com

Toll Free (US): +1-866-598-1553
Website @ https://www.precisionbusinessinsights.com

This release was published on openPR.